Investment Research & Advisory Group, Inc.
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1802136
ATLANTA, GA
Position in LGND
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$65,114
New position
Shares Held
206
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#338
of 411 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Investment Research & Advisory Group, Inc. holds $67,444 across 2 Biotechnology names. LGND ranks #1 (96.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
206 | $65,114 | |
| 2 | PLX |
Protalix BioTherapeutics, Inc.
|
1,000 | $2,330 |
All Filings in LGND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,114 | 206 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||